Rchr
J-GLOBAL ID:200901016079944744   Update date: Jun. 09, 2020

Kinoshita Ichiro

キノシタ イチロウ | Kinoshita Ichiro
Affiliation and department:
Job title: Lecturer
Research field  (1): Respiratory medicine
Research theme for competitive and other funds  (3):
  • 2008 - 2010 Identification of novel molecular targets for lung cancer based on different sensitivity to AP-1 blockade
  • 2004 - 2006 Research on Molecular Therapeutic Targets and Biomarkers for the Diagnosis and Stratification in Lung Cancer
  • 2004 - 2005 Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant negative mutant, TAM67
Papers (87):
  • Yasuyuki Ikezawa, Hajime Asahina, Satoshi Oizumi, Masahiro Watanabe, Kei Takamura, Yasutaka Kawai, Noriyuki Yamada, Toshiyuki Harada, Ichiro Kinoshita, Yuka Fujita, Eisaku Miyauchi, Takahiro Ogi, Toraji Amano, Megumi Furuta, Jun Sakakibara-Konishi, Hiroshi Nishihara, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura. A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002). CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2017. 80. 5. 955-963
  • Masahisa Jinushi, Tomoko Morita, Zhihang Xu, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Hideo Yagita, Yutaka Kawakami. Autophagy-dependent regulation of tumor metastasis by myeloid cells. PLOS ONE. 2017. 12. 7. e0179357
  • Jun Sakakibara-Konishi, Yasuyuki Ikezawa, Satoshi Oizumi, Junko Kikuchi, Eiki Kikuchi, Hidenori Mizugaki, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Masaharu Nishimura. Combined antitumor effect of gamma-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2017. 22. 2. 257-268
  • Yoshitaka Saito, Masaki Kobayashi, Takehiro Yamada, Kumiko Kasashi, Rio Honma, Satoshi Takeuchi, Yasushi Shimizu, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Ken Iseki. Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity. SUPPORTIVE CARE IN CANCER. 2017. 25. 2. 481-487
  • Kazuhiro Usui, Shunichi Sugawara, Masaru Nishitsuji, Yuka Fujita, Akira Inoue, Atsuto Mouri, Hiroshi Watanabe, Hiroshi Sakai, Ichiro Kinoshita, Yoshihito Ohhara, Makoto Maemondo, Hiroshi Kagamu, Koichi Hagiwara, Kunihiko Kobayashi. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A. LUNG CANCER. 2016. 99. 131-136
more...
MISC (28):
Education (2):
  • - 1988 Hokkaido University School of Medicine
  • - 1988 Hokkaido University Faculty of Medicine
Professional career (1):
  • MD, PhD (Hokkaido University)
Work history (4):
  • 2012/09 - 現在 Hokkaido University Associate Professor
  • 2005 - - Lecturer
  • 2004 - - Research Associate
  • 2001 - - Research Associate
Association Membership(s) (1):
American Society of Clinical Oncology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page